参考文献/References:
[1] Ralapanawa U,Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome:a narrative review[J]. J Epidemiol Glob Health,2021,11(2):169-177.
[2] Levine GN,McEvoy JW,Fang JC,et al. Management of patients at risk for and with left ventricular thrombus:a scientific statement from the American Heart Association[J]. Circulation,2022,146(15):e205-e223.
[3] Matsumoto M,Takei N,Mineki T,et al. Anticoagulant therapy with dual antiplatelet for left ventricular thrombus following acute myocardial infarction[J]. J Cardiol Cases,2020,22(3):114-116.
[4] ?ztürk C,Ustaba??o?lu FE. Apical thrombus mimicking ventricular septal rupture.[J]. J Invasive Cardiol,2024.DOI:10.25270/jic/24.00045.Online ahead of print.
[5] 何松坚,曾繁芳,刘长华,等. 急性ST段抬高型心肌梗死患者早期左心室血栓形成的临床特征及转归分析[J]. 中国动脉硬化杂志,2023,31(9):779-784.
[6] Yang Q,Quan X,Lang X,et al. Predicting thromboembolism in hospitalized patients with ventricular thrombus[J]. Rev Cardiovasc Med,2022,23(12):390.
[7] Wang P,Ye X,Yan D,et al. Incidence and risk factors of left ventricular thrombus in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention:a meta-analysis[J]. Med Princ Pract,2022,31(5):415-423.
[8] Lema?tre AI,Picard F,Maurin V,et al. Clinical profile and midterm prognosis of left ventricular thrombus in heart failure[J]. ESC Heart Fail,2021,8(2):1333-1341.
[9] Angebrandt Belo?evi? P,?malcelj A,Kos N,et al. Left ventricular ejection fraction can predict atrial thrombosis even in non-high-risk individuals with atrial fibrillation[J]. J Clin Med,2022,11(14):3965.
[10] Vallabhajosyula S,Kanwar S,Aung H,et al. Temporal trends and outcomes of left ventricular aneurysm after acute myocardial infarction[J]. Am J Cardiol,2020,133:32-38.
[11] Alexander Y,Osto E,Schmidt-Trucks?ss A,et al. Endothelial function in cardiovascular medicine:a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology,Aorta and Peripheral Vascular Diseases,Coronary Pathophysiology and Microcirculation,and Thrombosis[J]. Cardiovasc Res,2021,117(1):29-42.
[12] Kirsch J,Schneider H,Pagel JI,et al. Endothelial dysfunction,and a prothrombotic,proinflammatory phenotype is caused by loss of mitochondrial thioredoxin reductase in endothelium[J]. Arterioscler Thromb Vasc Biol,2016,36(9):1891-1899.
[13] Grover SP,Mackman N. Tissue factor:an essential mediator of hemostasis and trigger of thrombosis[J]. Arterioscler Thromb Vasc Biol,2018,38(4):709-725.
[14] Lin Y,Xie M,Qian M,et al. Cardiac fibroma:characteristics on echocardiography and cardiac magnetic resonance imaging[J]. QJM,2022,115(6):412-414.
[15] Galindo-Hayashi JM,Villarreal EG,Sanchez-Félix ER. Accessory mitral valve tissue:a differential diagnosis of an obstructive mass on the left ventricular outflow tract[J]. Cardiol Young,2023,33(12):2661-2663.
[16] Ji X,Zhang X. Left atrial myxoma with left ventricular myxoma diagnosed by ultrasound examination:a case report[J]. Medicine (Baltimore),2021,100(32):e26903.
[17] Kaewboonlert N,Chunharas P,Pluthikarmpae N,et al. Right ventricular outflow tract obstruction by cardiac hemangioma in asymptomatic patient[J]. J Surg Case Rep,2024,2024(5):rjae321.
[18] Li L,Meng J,Zhou X,et al. Surgical treatment of cardiac lipoma:20 years’ experience in a single center[J]. Chin Med J (Engl),2023,136(5):565-570.
[19] Ellen S,Emma H. Primary cardiac lymphoma:a case report[J]. Eur Heart J Case Rep,2023,7(4):ytad175.
[20] Bae DJ,Wadia SK,Kim JS,et al. Validity of echocardiography for detection of left ventricular thrombus with surgical validation in patients awaiting durable left ventricular assist device[J]. J Card Surg,2021,36(8):2722-2728.
[21] Fardman A,Massalha E,Natanzon SS,et al. Clinical predictors of left ventricular thrombus after myocardial infarction as detected by magnetic resonance imaging[J]. Front Cardiovasc Med,2024,10:1275390.
[22] Chaosuwannakit N,Makarawate P. Left Ventricular Thrombi:Insights from Cardiac Magnetic Resonance Imaging[J]. Tomography,2021,7(2):180-188.
[23] Hudec S,Hutyra M,Precek J,et al. Determination of the prevalence and predictors of ventricular thrombus with assessment of the risk of systemic embolization to the CNS in patients after acute myocardial infarction using magnetic resonance imaging,echocardiography and cardiac markers—A prospective,unicentric,observational study[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2023.DOI:10.5507/bp.2023.050.Online ahead of print.
[24] Chun SH,Suh YJ,Han K,et al. Differentiation of left atrial appendage thrombus from circulatory stasis using cardiac CT radiomics in patients with valvular heart disease[J]. Eur Radiol,2021,31(2):1130-1139.
[25] Guo C,Jiang Z,He J,et al. Impact of left atrial appendage thrombus location on diagnostic accuracy of cardiac CT:a single-centre case-control study[J]. BMJ Open,2024,14(1):e079876.
[26] Ardipradja KS,Wichmann CW,Hickson K,et al. 18F site-specific labelling of a single-chain antibody against activated platelets for the detection of acute thrombosis in positron emission tomography[J]. Int J Mol Sci,2022,23(13):6886.
[27] Wang S,Cheng Z,Cui Y,et al. 18F-FAPI-42 PET/CT findings in a patient with left ventricular mural thrombus[J]. Clin Nucl Med,2024,49(3):274-275.
[28] Wu HS,Dong JZ,Du X,et al. Risk factors for left ventricular thrombus formation in patients with dilated cardiomyopathy[J]. Semin Thromb Hemost,2023,49(7):673-678.
[29] Chikata A,Kato T,Murata A,et al. Cardiac thrombus growth without D-dimer elevation in atrial fibrillation-mediated cardiomyopathy[J]. J Interv Card Electrophysiol,2022,64(2):265-266.
[30] Mathews R,Setthavongsack N,Le-Cook A,et al. Role of platelet count in a murine stasis model of deep vein thrombosis[J]. Platelets,2024,35(1):2290916.
[31] 罗玉清,蒋靖波,李金轶,等. 急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后左心室血栓的危险因素分析[J]. 临床内科杂志,2024,41(3):165-169.
[32] 呼日乐巴特尔,吴红丽,刘雪婷,等. 老年急性前壁心肌梗死急诊经皮冠脉介入术后早期左心室血栓形成的预测因素[J]. 实用医学杂志,2023,39(17):2230-2235.
[33] Lattuca B,Bouziri N,Kerneis M,et al. Antithrombotic therapy for patients with left ventricular mural thrombus[J]. J Am Coll Cardiol,2020,75(14):1676-1685.
[34] 周强,臧月月,陶瑛瑛,等. 新型口服抗凝药对比华法林用于左心室血栓有效性和安全性的Meta分析[J]. 中国药房,2022,33(24):3034-3039.
[35] Byrne RA,Rossello X,Coughlan JJ,et al. 2023 ESC Guidelines for the management of acute coronary syndromes[J]. Eur Heart J,2023,44(38):3720-3826.
[36] de Luca L,Putini RL,Natale E,et al. One-year clinical outcome of patients with left ventricular thrombus after acute myocardial infarction discharged on triple or dual antithrombotic therapy[J]. J Thromb Thrombolysis,2022,53(2):410-416.
[37] Toufic El Hussein M,Mikhail M. Evidence-based recommendations:management of left ventricular thrombus post-acute myocardial infarction[J]. Dimens Crit Care Nurs,2022,41(6):313-320.
[38] 梁卫东,徐锦明,黄彩芳,等. 溶栓后转运经皮冠脉介入术和直接转运经皮冠脉介入术的临床疗效和心血管不良事件的比较[J]. 中华高血压杂志,2023,31(9):870-876.
[39] Zhao X,Zhu Y,Zhang Z,et al. Tenecteplase versus alteplase in treatment of acute ST-segment elevation myocardial infarction:a randomized non-inferiority trial[J]. Chin Med J (Engl),2024,137(3):312-319.
[40] Eranki A,Villanueva C,Collins N,et al. Video assisted,transaortic removal of left ventricular thrombus during concurrent cardiac surgery:a case report[J]. J Cardiothorac Surg,2021,16(1):242.
[41] Machado JDMF,Marta-Enguita J,Gómez SU,et al. Transcriptomic analysis of extracellular vesicles in the search for novel plasma and thrombus biomarkers of ischemic stroke etiologies[J]. Int J Mol Sci,2024,25(8):4379.
[42] Pawlowski CL,Li W,Sun M,et al. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis[J]. Biomaterials,2017,128:94-108.
[43] Hou YC,Li JA,Zhu SJ,et al. Tailoring of cardiovascular stent material surface by immobilizing exosomes for better pro-endothelialization function[J]. Colloids Surf B Biointerfaces,2020,189:110831.
相似文献/References:
[1]王铁华,郑景辉,莫云秋.蛋白质组学在心肌梗死中的研究进展[J].心血管病学进展,2015,(5):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
WANG Tiehua,ZHENG Jinghui,MO Yunqiu.Research Progress of Proteomics in Myocardial Infarction[J].Advances in Cardiovascular Diseases,2015,(12):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
[2]孙洋.基质金属蛋白酶与心肌梗死后心脏重构[J].心血管病学进展,2019,(8):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
SUN Yang.Matrix Metalloproteinases in Cardiac Remodeling after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(12):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
[3]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(12):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[4]常文婧 王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J].心血管病学进展,2019,(8):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
CHANG Wenjin,WANG Lina.Role of Hippo Pathway in Heart Development,Regeneration and Disease[J].Advances in Cardiovascular Diseases,2019,(12):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
[5]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(12):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[6]邹先明 赵然尊.长链非编码RNA ANRIL与心血管疾病的研究进展[J].心血管病学进展,2020,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
ZOU Xianming,ZHAO Ranzun.Long Non-Coding RNA ANRIL and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(12):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[7]王茜 李晶洁.细胞学机制在调控心肌梗死后炎症反应中的研究进展[J].心血管病学进展,2020,(2):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
WANG QianLI Jingjie.Cytological Mechanisms in Regulation of The Post-infarction Inflammatory Response[J].Advances in Cardiovascular Diseases,2020,(12):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
[8]黄柳,张瑞宁,田小超,等.内皮祖细胞与冠心病患者CD14CD16+单核细胞共培养后移植心肌梗死大鼠对血管密度及心肌梗死面积的影响[J].心血管病学进展,2020,(2):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
HUANG Liu,ZHANG Ruining,TIAN Xiaochao,et al.Effects of Co-cultured Endothelial Progenitor Cells and CD14++CD16+ Monocytes from Coronary Heart Disease Patients on Vascular Density and Myocardial Infarction Size in Transplanting Myocardial Infarction Rats[J].Advances in Cardiovascular Diseases,2020,(12):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
[9]刘玉婷,贾锋鹏.骨膜蛋白与心血管疾病的研究进展[J].心血管病学进展,2020,(3):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
LIU Yuting,JIA Fengpeng.Roles of Periostin in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(12):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
[10]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(12):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]